Oral Hormone Replacement Therapy Raises Blood Clot Risk
Key Points Oral hormone replacement therapy was associated with a higher risk of venous thromboembolism (VTE) among women aged 50–69
Read MoreKey Points Oral hormone replacement therapy was associated with a higher risk of venous thromboembolism (VTE) among women aged 50–69
Read MoreIn order to identify potential proteins (biomarkers) linked to subsequent cognitive problems, including serious and persistent problems with thinking, concentration,
Read MoreA recent comprehensive Danish study published in The BMJ suggests that women who combine hormonal contraception with non-steroidal anti-inflammatory painkillers
Read More